Advertisement

Picture EBD Group BioPharm America 2018 Boston Speakers 600x60px
Document › Details

Waters Corporation. (4/3/18). "Press Release: Waters Corporation to Invest $215 Million in Precision Chemistry Manufacturing in Massachusetts". Milford, MA.

Organisations Organisation Waters Corporation, Chemical Manufacturing Plant in Taunton, MA, USA
  Group Waters (Group)
  Organisation 2 Waters Corporation (NYSE: WAT)
  Group Waters (Group)
Products Product CHEMICALS
  Product 2 chromatography
Persons Person O’Connell, Christopher J. (Chris) (Waters 201509– CEO before over 21 years at Medtronic)
  Person 2 Brokmeier, Bryan (Waters 201801 Senior Director Investor Relations)
     


New State-of-the-Art Facility Will Support Continued Growth and Innovation


Following recent approval by its Board of Directors, Waters Corporation (NYSE: WAT) announced plans to significantly expand its precision chemistry operation in Taunton, Mass. The company anticipates investing approximately $215 million to build and equip a new state-of-the-art facility that will support rising global customer demand, as well as ongoing innovation in chemistry technology.

The company's Taunton, Massachusetts site is responsible for bulk synthesis of chromatographic media which is critical to sample analysis for pharmaceutical, biopharmaceutical, materials, food, clinical and biomedical research applications.

"Our portfolio of innovative precision chemistry products is critical to scientific advancements in the life, materials and food sciences," said Christopher J. O'Connell, Waters Corporation Chairman and CEO. The expansion of our Taunton facility will ensure Waters customers continue to benefit from the most innovative chromatography particle R&D and the highest quality production in the industry."

The Taunton project is a noteworthy example of Waters’ capital allocation strategy, which prioritizes investing for long term growth and innovation. The return on this investment will be enhanced by the company's access to capital following U.S. tax reform, as well as the strong partnership of the Commonwealth of Massachusetts and the City of Taunton.

The company plans to employ LEED certification standards as well as state-of-the-art manufacturing and process technology to construct a new center-of-excellence that meets output, cost, quality and sustainability objectives. Specific plans remain subject to refinement, however the company expects the new plant will be operational by 2022. Until then, the existing Taunton facility will fully meet operational and growth needs.


About Waters Corporation (www.waters.com)

Waters Corporation (NYSE: WAT), the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for 60 years. With approximately 7,000 employees worldwide, Waters operates directly in 31 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.

Waters is a registered trademark of the Waters Corporation.


Waters Corporation
Bryan Brokmeier, 508-482-3448
Investor Relations
byran_brokmeier@waters.com

or

Chris Orlando, 508-482-2623
Senior Public Relations Manager
Chris_Orlando@waters.com

   
Record changed: 2018-05-29

Advertisement

Picture [LSG] Life-Sciences-Germany.com – The Business Web Portal 600x80px

More documents for Waters (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group BioPharm America 2018 Boston September 600x60px




» top